General Overview:

Ipamorelin is a selective growth hormone secretagogue researched for its ability to stimulate the body’s natural release of growth hormone. Unlike some earlier compounds in this category, it is studied for its more targeted action with minimal impact on other hormones such as cortisol or prolactin.

In experimental settings, scientists explore its effects on growth hormone pulses, recovery, body composition, and related metabolic processes.

Technical Overview

Ipamorelin is a synthetic pentapeptide developed for laboratory investigation involving growth hormone secretagogue receptor (GHS-R) interactions and peptide signaling pathways in controlled research environments. It is commonly examined in experimental settings focused on receptor-specific activity, peptide behavior, and analytical assay applications.

This compound is typically synthesized using solid-phase peptide synthesis and purified through HPLC to achieve analytical purity suitable for research use. Its lyophilized peptide powder format supports stable handling and storage under recommended laboratory conditions.

Specifications

Compound Name: Ipamorelin Available Strengths: 5 mg · 10 mg. Format: Research Peptide Appearance: Lyophilized Peptide Powder Purity: ≥ 99% (HPLC Verified) Storage: −20°C recommended

Notice

This compound is provided strictly as a reference reagent for scientific and laboratory investigation. Research Use Only. Not for Human Use.